NCT07603479 JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE1
NCT07574346 IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies Status RECRUITING Phase EARLY_PHASE1
NCT06703853 Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05929495 Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma Status RECRUITING Phase PHASE2
NCT05602103 Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies Status NOT_YET_RECRUITING Phase N/A
NCT05253105 A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies Status WITHDRAWN Phase PHASE1
NCT03384511 The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Status COMPLETED Phase PHASE4
NCT03236857 A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies Status COMPLETED Phase PHASE1
NCT03005782 Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers Status COMPLETED Phase PHASE1
NCT02521389 Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 Status COMPLETED Phase PHASE1
NCT02257476 Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01407380 Study of PWT33597 Mesylate in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01404728 Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy Status COMPLETED Phase N/A
NCT00329329 Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies Status TERMINATED Phase PHASE1
NCT00320827 Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) Status COMPLETED Phase PHASE1
NCT00316511 Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma Status COMPLETED Phase PHASE1